,"Author: Dalakas, Marinos C.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 43 (Of the 193 documents considered for the h-Index, 43 have been cited at least 43 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,10304,1246,1060,2306,708,13318
2009,Toxic and drug-induced myopathies,Dalakas M.C.,223050,"Journal of Neurology, Neurosurgery and Psychiatry",80,8,0,0,0,0,0,0
2009,Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis,"Dalakas M.C., Kampen R.L., Bruno D.A., Kirk A.D., Rakocevic G., Schmidt J., Salajegheh M., McElroy B., Harris-Love M.O., Shrader J.A., Levy E.W., Dambrosia J.",68950,Brain,132,6,0,0,0,0,0,0
2009,Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study,"Merkies I.S.J., Van Doorn P.A., Bril V., Dalakas M.C., Deng C., Donofrio P., Hanna K., Hartung H.-P., Hughes R.A.C., Latov N.",283878,Neurology,72,15,0,0,0,0,1,1
2009,Electrophysiology in chronic inflammatory demyellnatlng polyneuropathy with IGIV,"Bril V., Latov N., Merkies I.S.J., Van Doorn P.A., Katzberg H., Donofrio P., Banach M., Dalakas M.C., Deng C., Hanna K., Hartung H.-P., Hughes R.A.C.",0148639X,Muscle and Nerve,39,4,0,0,0,0,1,1
2009,Inflammation interrelates to APP in sIBM: IL-1? induces accumulation of ?-amyloid,"Schmidt J., Dalakas M.C.",68950,Brain,132,4,0,0,0,0,0,0
2009,Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy,"Dalakas M.C., Rakocevic G., Salajegheh M., Dambrosia J.M., Hahn A.F., Raju R., McElroy B.",3645134,Annals of Neurology,65,3,0,0,0,0,3,3
2009,Stiff person syndrome: Advances in pathogenesis and therapeutic interventions,Dalakas M.C.,10928480,Current Treatment Options in Neurology,11,2,0,0,0,0,0,0
2009,Targeting B cells in multiple sclerosis. Current concepts and strategies | B-zell-gerichtete multiple-sklerose-therapie. Aktueller stand,"Menge T., Budingen H.-C., Dalakas M.C., Kieseier B.C., Hartung H.-P.",282804,Nervenarzt,80,2,0,0,0,0,0,0
2009,In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy,"Shatunov A., Chinnery P.F., Straub V., Hilton-Jones D., Damian M.S., Kaminska A., Vicart P., Bushby K., Dalakas M.C., Sambuughin N., Ferrer I., Olive M., Goebel H.H., Goldfarb L.G., Odgerel Z., Stadelmann-Nessler C., Irlbacher K., van Landeghem F., Bayarsaikhan M., Lee H.-S., Goudeau B.",10184813,European Journal of Human Genetics,17,5,0,0,0,0,0,0
2008,B cells as therapeutic targets in autoimmune neurological disorders,Dalakas M.C.,1745834X,Nature Clinical Practice Neurology,4,10,0,0,0,0,9,9
2008,"A ""nema"" of hope in the treatment of late-onset nemaline myopathy","Dalakas M.C., Smith S.A.",283878,Neurology,71,7,0,0,0,0,1,1
2008,"Interplay between inflammation and degeneration: Using inclusion body myositis to study ""neuroinflammation""",Dalakas M.C.,3645134,Annals of Neurology,64,1,0,0,1,1,1,2
2008,IVIg in other autoimmune neurological disorders: Current status and future prospects,Dalakas M.,3405354,Journal of Neurology,255,3,0,0,0,0,2,2
2008,Invited article: Inhibition of B cell functions: Implications for neurology,Dalakas M.C.,283878,Neurology,70,23,0,0,3,3,11,14
2008,Interrelation of inflammation and APP in sIBM: IL-1? induces accumulation of ?-amyloid in skeletal muscle,"Schmidt J., Barthel K., Wrede A., Salajegheh M., Bahr M., Dalakas M.C.",68950,Brain,131,5,0,0,4,4,11,15
2008,A focused microarray to study human mitochondrial and nuclear gene expression,"Voss J.G., Raju R., Logun C., Danner R.L., Munson P.J., Rangel Z., Dalakas M.C.",10998004,Biological Research for Nursing,9,4,0,0,0,0,0,0
2008,Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial,"Hughes R.A., van Doorn P.A., Donofrio P., Bril V., Dalakas M.C., Deng C., Hanna K., Hartung H.-P., Latov N., Merkies I.S.",14744422,The Lancet Neurology,7,2,0,0,14,14,20,34
2008,"Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: Present and future prospects (Journal of Neurology (2006) 253, (SUPPL. 5) (25-32) DOI: 10.1007/s00415-006-5004-0)",Dalakas M.C.,3405354,Journal of Neurology,255,2,0,0,0,0,0,0
2008,High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome,"Burbelo P.D., Groot S., Dalakas M.C., Iadarola M.J.",0006291X,Biochemical and Biophysical Research Communications,366,1,0,0,5,5,6,11
2008,Advances in the pathogenesis and treatment of patients with stiff person syndrome,Dalakas M.C.,15284042,Current Neurology and Neuroscience Reports,8,1,0,0,2,2,2,4
2008,Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG,"Ilyas A.A., Gu Y., Dalakas M.C., Quarles R.H., Bhatt S.",1655728,Journal of Neuroimmunology,193, 1-2,0,0,1,1,2,3
2007,Autoimmune inflammatory myopathies,Dalakas M.C.,729752,Handbook of Clinical Neurology,86, ,0,0,0,0,0,0
2007,T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis,"Salajegheh M., Rakocevic G., Raju R., Shatunov A., Goldfarb L.G., Dalakas M.C.",283878,Neurology,69,17,0,0,3,3,2,5
2007,Advances in the immunobiology and treatment of inflammatory myopathies,Dalakas M.C.,15233774,Current Rheumatology Reports,9,4,0,1,1,2,1,3
2007,"Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis","Salajegheh M., Raju R., Schmidt J., Dalakas M.C.",1655728,Journal of Neuroimmunology,187, 1-2,0,0,0,0,1,1
2007,Macroautophagy as a pathomechanism in sporadic inclusion body myositis,"Lunemann J.D., Schmidt J., Dalakas M.C., Munz C.",15548627,Autophagy,3,4,0,3,2,5,2,7
2007,?-amyloid is a substrate of autophagy in sporadic inclusion body myositis,"Lunemann J.D., Schmidt J., Schmid D., Barthel K., Wrede A., Dalakas M.C., Munz C.",3645134,Annals of Neurology,61,5,0,5,7,12,12,24
2007,Modafinil for treatment of fatigue in post-polio syndrome: A randomized controlled trial,"Vasconcelos O.M., Jabbari B., Campbell W.W., Prokhorenko O.A., Salajegheh M.K., Kelley K.F., Livornese K., Olsen C.H., Vo A.H., Dalakas M.C., Halstead L.S.",283878,Neurology,68,20,0,0,1,1,1,2
2007,Inclusion body myositis with human immunodeficiency virus infection: Four cases with clonal expansion of viral-specific T cells,"Dalakas M.C., Rakocevic G., Shatunov A., Goldfarb L., Raju R., Salajegheh M.",3645134,Annals of Neurology,61,5,0,1,7,8,4,12
2007,Reply from the author [2],Dalakas M.C.,283878,Neurology,68,14,0,0,0,0,0,0
2007,Absence of upregulated genes associated with protein accumulations in desmin myopathy,"Raju R., Dalakas M.C.",0148639X,Muscle and Nerve,35,3,0,1,0,1,2,3
2007,Intravenous immune globulin in hereditary inclusion body myopathy: A pilot study,"Sparks S., Krasnewich D., Huizing M., Dalakas M.C., Gahl W.A., Rakocevic G., Joe G., Manoli I., Shrader J., Harris-Love M., Sonies B., Ciccone C., Dorward H.",14712377,BMC Neurology,7, ,0,1,2,3,2,5
2007,Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins,"Lupu V.D., Mora C.A., Dambrosia J., Meer J., Dalakas M., Floeter M.K.",0148639X,Muscle and Nerve,35,2,0,0,2,2,1,3
2007,Ill-defined neurological syndromes with autoimmune background: A diagnostic challenge,"Mavragani C.P., Patronas N., Dalakas M., Moutsopoulos H.M.",0315162X,Journal of Rheumatology,34,2,0,0,0,0,0,0
2007,Drug Insight: The use of intravenous immunoglobulin in neurology - Therapeutic considerations and practical issues,"Gold R., Stangel M., Dalakas M.C.",1745834X,Nature Clinical Practice Neurology,3,1,0,11,25,36,8,44
2006,Dermatomyositis,Dalakas M.C.,15715078,Handbook of Systemic Autoimmune Diseases,5, ,0,0,0,0,0,0
2006,Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome,"Raju R., Rakocevic G., Chen Z., Hoehn G., Semino-Mora C., Shi W., Olsen R., Dalakas M.C.",68950,Brain,129,12,0,5,12,17,4,21
2006,B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target,Dalakas M.C.,1637258,Pharmacology and Therapeutics,112,1,0,3,6,9,1,10
2006,"Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: Present and future prospects",Dalakas M.C.,3405354,Journal of Neurology,253,5,0,2,0,2,2,4
2006,A Comparison of Fatigue Scales in Postpoliomyelitis Syndrome,"Vasconcelos Jr. O.M., Prokhorenko O.A., Kelley K.F., Vo A.H., Olsen C.H., Dalakas M.C., Halstead L.S., Jabbari B., Campbell W.W.",39993,Archives of Physical Medicine and Rehabilitation,87,9,0,2,1,3,2,5
2006,The challenge of diagnosing ALS in patients with prior poliomyelitis,"Salajegheh M., Bryan W.W., Dalakas M.C.",283878,Neurology,67,6,0,0,0,0,0,0
2006,Variable pathogenic potentials of mutations located in the desmin alpha-helical domain,"Goudeau B., Sjoberg G., Kostareva A., Sejersen T., Dalakas M.C., Goldfarb L.G., Vicart P., Rodrigues-Lima F., Fischer D., Casteras-Simon M., Sambuughin N., De Visser M., Laforet P., Ferrer X., Chapon F.",10597794,Human Mutation,27,9,0,4,3,7,2,9
2006,Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies,"Rakocevic G., Raju R., Semino-Mora C., Dalakas M.C.",283878,Neurology,67,6,1,4,7,11,1,13
2006,"Sporadic inclusion body myositis - Diagnosis, pathogenesis and therapeutic strategies",Dalakas M.C.,1745834X,Nature Clinical Practice Neurology,2,8,0,12,18,30,14,44
2006,Erratum: Mechanisms of disease: Signaling pathways and immunobiology of inflammatory myopathies (Nature Clinical Practice Rheumatology (2006) vol. 2 (219-227) 10.1038/ncprheum0140),Dalakas M.C.,17458382,Nature Clinical Practice Rheumatology,2,7,0,0,0,0,0,0
2006,Update on idiopathic inflammatory myopathies,"Briani C., Doria A., Sarzi-Puttini P., Dalakas M.C.",8916934,Autoimmunity,39,3,0,7,8,15,5,20
2006,Therapeutic targets in patients with inflammatory myopathies: Present approaches and a look to the future,Dalakas M.C.,9608966,Neuromuscular Disorders,16,4,1,3,6,9,3,13
2006,Mechanisms of disease: Signaling pathways and immunobiology of inflammatory myopathies,Dalakas M.C.,17458382,Nature Clinical Practice Rheumatology,2,4,3,7,4,11,2,16
2006,The role of high-dose immune globulin intravenous in the treatment of dermatomyositis,Dalakas M.C.,15675769,International Immunopharmacology,6,4,3,8,5,13,3,19
2006,Diagnosis and treatment of chronic immune-mediated neuropathies,"Latov N., Busis N.A., Cros D.P., Dalakas M.C., Donofrio P.D., England J.D., Fisher M.A., Herrmann D.N., Menkes D.L., Sahenk Z., Gorson K.C., Sander H.W., Triggs W.J., Vallat J.M., Brannagan III T.H., Freeman R.L., Apostolski S., Berger A.R., Bradley W.G., Briani C., Bril V.",15220443,Journal of Clinical Neuromuscular Disease,7,3,0,2,1,3,0,3
2006,"Inflammatory, immune, and viral aspects of inclusion-body myositis",Dalakas M.C.,283878,Neurology,66,2,6,12,7,19,8,33
2006,Skin involvement and outcome measures in systemic autoimmune diseases,"Albrecht J., Sarzi-Puttini P., Atzeni F., Baldini C., Bombardieri S., Dalakas M.C., Demirkesen C., Yazici H., Mat C., Werth V.P.",0392856X,Clinical and Experimental Rheumatology,24,40,2,1,1,2,0,4
2006,"Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands","Schreiner B., Voss J., Wischhusen J., Dombrowski Y., Steinle A., Lochmuller H., Dalakas M., Melms A., Wiendl H.",8926638,FASEB Journal,20,1,5,5,4,9,2,16
2006,"Inclusion-body myositis: Clinical and pathologic aspects, and basic research potentially relevant to treatment","Askanas V., Dalakas M.C., Engel W.K.",283878,Neurology,66,2,1,0,1,1,0,2
2005,Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: Effects on clinicopathological features and immunoregulatory genes,Dalakas M.C.,10800549,Clinical Reviews in Allergy and Immunology,29,3,0,0,1,1,1,2
2005,Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients,"Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., Ortqvist E., Hampe C.S.",221767,Journal of Immunology,175,11,8,9,13,22,4,34
2005,Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy,"Sparks S.E., Huizing M., Ciccone C., Lalor M., Orvisky E., Klootwijk R., Savelkoul P.J., Dalakas M.C., Krasnewich D.M., Gahl W.A.",9596658,Glycobiology,15,11,2,4,3,7,1,10
2005,Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations,"Sivakumar K., Zamba-Papanicolaou E., Ionasescu V., Dalakas M.C., Green E.D., Fischbeck K.H., Goldfarb L.G., Kyriakides T., Puls I., Nicholson G.A., Funalot B., Antonellis A., Sambuughin N., Christodoulou K., Beggs J.L.",68950,Brain,128,10,11,7,5,12,3,26
2005,Single nucleotide polymorphisms in the dystroglycan gene do not correlate with disease severity in hereditary inclusion body myopathy,"Gottlieb E., Ciccone C., Darvish D., Naiem-Cohen S., Dalakas M.C., Savelkoul P.J., Krasnewich D.M., Gahl W.A., Huizing M.",10967192,Molecular Genetics and Metabolism,86, 1-2,2,2,0,2,1,5
2005,Gene expression profile in the muscles of patients with inflammatory myopathies: Effect of therapy with IVIg and biological validation of clinically relevant genes,"Raju R., Dalakas M.C.",68950,Brain,128,8,18,21,10,31,3,52
2005,A neuropsychological assessment of phobias in patients with stiff person syndrome,"Ameli R., Snow J., Rakocevic G., Dalakas M.C.",283878,Neurology,64,11,2,1,1,2,1,5
2005,Brain ?-aminobutyric acid changes in stiff-person syndrome,"Levy L.M., Levy-Reis I., Fujii M., Dalakas M.C.",39942,Archives of Neurology,62,6,7,2,7,9,2,18
2005,Autoimmune muscular pathologies,Dalakas M.C.,15901874,Neurological Sciences,26,1,1,0,0,0,1,2
2005,The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.,Dalakas M.C.,3405354,Journal of neurology,252, ,7,3,8,11,3,21
2005,Gene expression profiling in chronic inflammatory demyelinating polyneuropathy,"Renaud S., Danon M.J., Latov N., Hays A.P., Brannagan III T.H., Sander H.W., Edgar M., Weimer L.H., Olarte M.R., Dalakas M.C., Xiang Z.",1655728,Journal of Neuroimmunology,159, 1-2,5,2,4,6,1,12
2004,Molecular pathogenesis of inflammatory myopathies and future therapeutic strategies.,Dalakas M.C.,1567424X,Supplements to Clinical neurophysiology,57, ,0,0,2,2,0,2
2004,Inhibiting leukocyte recruitment to the brain by IVIg: Is it relevant to the treatment of demyelinating CNS disorders?,Dalakas M.C.,68950,Brain,127,12,5,0,0,0,0,5
2004,Correlating phenotype and genotype in the periodic paralyses,"Miller T.M., Servidei S., Petajan J., Dalakas M.C., Ranum L.P.W., Fu Y.H., Ptacek L.J., Dias Da Silva M.R., Miller H.A., Kwiecinski H., Mendell J.R., Tawil R., McManis P., Griggs R.C., Angelini C.",283878,Neurology,63,9,13,5,14,19,3,35
2004,"Inflammatory disorders of muscle: Progress in polymyositis, dermatomyositis and inclusion body myositis",Dalakas M.C.,13507540,Current Opinion in Neurology,17,5,22,9,7,16,6,44
2004,Intravenous immunoglobulin and quality of life [4] (multiple letters),"Padua L., Aprile I., Caliandro P., Pazzaglia C., Tonali P., Dalakas M.C.",987484,Journal of the American Medical Association,292,12,1,0,0,0,0,1
2004,"From canine to man: On antibodies, macrophages, and dendritic cells in inflammatory myopathies",Dalakas M.C.,0148639X,Muscle and Nerve,29,6,3,4,1,5,0,8
2004,The molecular pathophysiology in inflammatory myopathies,Dalakas M.C.,2488663,Revue de Medecine Interne,25,1,0,0,1,1,1,2
2004,The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Evidence-based indications and safety profile,Dalakas M.C.,1637258,Pharmacology and Therapeutics,102,3,38,17,15,32,9,79
2004,"The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: A view to the future from the ""bench-to- bedside""",Dalakas M.C.,3405354,Journal of Neurology,251,6,4,0,0,0,1,5
2004,Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: Correlation with clinical severity,"Rakocevic G., Raju R., Dalakas M.C.",39942,Archives of Neurology,61,6,14,3,9,12,2,28
2004,Inflammatory myopathies: Update on the molecular pathogenesis of inflammatory myopathies,Dalakas M.C.,15689972,Autoimmunity Reviews,3,1,0,0,2,2,0,2
2004,Intravenous immunoglobulin in autoimmune neuromuscular diseases,Dalakas M.C.,987484,Journal of the American Medical Association,291,19,58,24,17,41,11,110
2004,Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: Significance for CD8+ T cell cytotoxicity,"Schmidt J., Rakocevic G., Raju R., Dalakas M.C.",68950,Brain,127,5,12,8,7,15,4,31
2004,Desmin myopathy,"Goldfarb L.G., Vicart P., Goebel H.H., Dalakas M.C.",68950,Brain,127,4,39,24,20,44,9,92
2004,Hypoglycosylation of ?-dystroglycan in patients with hereditary IBM due to GNE mutations,"Huizing M., Rakocevic G., Sparks S.E., Mamali I., Shatunov A., Goldfarb L., Krasnewich D., Gahl W.A., Dalakas M.C.",10967192,Molecular Genetics and Metabolism,81,3,21,6,6,12,3,36
2004,Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy,"Kaminska A., Ferrer I., Kwiecinski H., Vicart P., Goldfarb L.G., Strelkov S.V., Goudeau B., Olive M., Dagvadorj A., Fidzianska A., Simon-Casteras M., Shatunov A., Dalakas M.C.",3406717,Human Genetics,114,3,12,12,4,16,4,32
2004,A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin,"Dagvadorj A., Vicart P., Dalakas M.C., Goldfarb L.G., Olive M., Urtizberea J.-A., Halle M., Shatunov A., Bonnemann C., Park K.-Y., Goebel H.H., Ferrer I.",3405354,Journal of Neurology,251,2,7,3,4,7,1,15
2003,Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy,"Berger A.R., England J.D., Feldman E.L., Freeman R.L., Kinsella L.J., Lacomis D., Latov N., Menkes D.L., Sander H.W., Thomas F.P., Triggs W.J., Bradley W.G., Windebank A.J., Wolfe G.I., Brannagan T.H., Busis N.A., Cros D.P., Dalakas M.C., Danon M.J., Donofrio P.D., Engel W.K.",10859489,Journal of the Peripheral Nervous System,8,4,16,3,1,4,2,22
2003,Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy,"McCrone P., Swan A., Van Bergh P.D., Willison H.J., Chisholm D., Knapp M., Hughes R., Comi G., Dalakas M.C., Illa I., Kilindireas C., Nobile-Orazio E.",13515101,European Journal of Neurology,10,6,14,5,2,7,6,27
2003,"Enteroviruses in chronic fatigue syndrome: ""Now you see them, now you don't""",Dalakas M.C.,223050,"Journal of Neurology, Neurosurgery and Psychiatry",74,10,3,0,0,0,0,3
2003,High-dose intravenous immunoglobulin in inflammatory myopathies: Experience based on controlled clinical trials,Dalakas M.C.,15901874,Neurological Sciences,24,4,9,3,5,8,2,19
2003,Polymyositis and dermatomyositis,"Dalakas M.C., Hohlfeld R.",1406736,Lancet,362,9388,140,57,48,105,34,279
2003,Expression of IFN-?-inducible chemokines in inclusion body myositis,"Raju R., Vasconcelos O., Granger R., Dalakas M.C.",1655728,Journal of Neuroimmunology,141, 1-2,14,7,7,14,1,29
2003,Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): A case report,"Ho N.C., Sandusky S., Madike V., Francomano C.A., Dalakas M.C.",14712377,BMC Neurology,3, ,2,1,0,1,0,3
2003,"Strokes, thromboembolic events, and IVIg: Rare incidents blemish an excellent safety record","Dalakas M.C., Clark W.M.",283878,Neurology,60,11,23,7,3,10,3,36
2003,Neuroimmunotherapy: Preface,Dalakas M.C.,2718235,Seminars in Neurology,23,2,1,0,0,0,0,1
2003,Neuroimmunotherapy: Introduction to guest editor,"Dalakas M.C., Roos K.L.",2718235,Seminars in Neurology,23,2,0,0,0,0,0,0
2003,Basic principles of immunotherapy for neurologic diseases,"Hohlfeld R., Dalakas M.C.",2718235,Seminars in Neurology,23,2,5,2,0,2,1,8
2003,Therapeutic approaches in patients with inflammatory myopathies,Dalakas M.C.,2718235,Seminars in Neurology,23,2,23,4,3,7,1,31
2003,"Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations","Dalakas M.C., Nagle J.W., Sivakumar K., Vicart P., Goldfarb L.G., Dagvadorj A., Goudeau B., Park K.-Y., Takeda K., Simon-Casteras M., Vasconcelos O., Sambuughin N., Shatunov A.",9608966,Neuromuscular Disorders,13,3,7,9,3,12,1,20
2003,Immunotherapy in autoimmune neuromuscular disorders,"Gold R., Dalakas M.C., Toyka K.V.",14744422,Lancet Neurology,2,1,21,3,3,6,1,28
2002,Immune mechanisms in chronic inflammatory demyelinating neuropathy,"Kieseier B.C., Dalakas M.C., Hartung H.-P.",283878,Neurology,59,12,27,3,4,7,2,36
2002,Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies,Dalakas M.C.,283878,Neurology,59,12,39,9,7,16,4,59
2002,Pro-inflammatory cytokines and motor neuron dysfunction: Is there a connection in post-polio syndrome?,Dalakas M.C.,0022510X,Journal of the Neurological Sciences,205,1,3,2,1,3,1,7
2002,GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM,"Vasconcelos O.M., Raju R., Dalakas M.C.",283878,Neurology,59,11,15,5,1,6,2,23
2002,Desmin myopathy: Distinct filamentopathy caused by mutations in the desmin gene,"Dalakas M.C., Vasconcelos O.M., Kaminska A., Kwiesciski H., Hilton-Jones D., Squier W., Goldfarb L.G.",11282460,Acta Myologica,21, ,2,0,0,0,1,3
2002,Muscle biopsy findings in inflammatory myopathies,Dalakas M.C.,0889857X,Rheumatic Disease Clinics of North America,28,4,27,7,6,13,3,43
2002,Understanding the immunopathogenesis of inclusion-body myositis: Present and future prospects,Dalakas M.C.,353787,Revue Neurologique,158, 10 I,14,2,0,2,1,17
2002,Increased brainstem excitability in stiff-person syndrome,"Molloy F.M., Dalakas M.C., Floeter M.K.",283878,Neurology,59,3,7,1,0,1,1,9
2002,"Blockade of blocking antibodies in Guillain-Barré syndromes: ""Unblocking"" the mystery of action of intravenous immunoglobulin",Dalakas M.C.,3645134,Annals of Neurology,51,6,10,1,1,2,0,12
2002,High-dose intravenous immune globulin for stiff-person syndrome [2] (multiple letters),"Sudo K., Tajima Y., Matsumoto A., Solaro C., Dalakas M.C.",284793,New England Journal of Medicine,346,22,1,0,0,0,0,1
2002,"Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia","Arikawa-Hirasawa E., Spranger J., Stevenson R.E., Iannaccone S., Dalakas M.C., Yamada Y., Le A.H., Nishino I., Nonaka I., Ho N.C., Francomano C.A., Govindraj P., Hassell J.R., Devaney J.M.",29297,American Journal of Human Genetics,70,5,43,4,3,7,6,56
2002,Inflammatory myopathies. Recent advances in pathogenesis and therapy.,Dalakas M.C.,913952,Advances in neurology,88, ,11,0,0,0,0,11
2001,High-dose intravenous immune globulin for stiff-person syndrome,"Dalakas M.C., Fujii M., Li M., Lutfi B., Kyhos J., McElroy B.",284793,New England Journal of Medicine,345,26,72,16,10,26,7,105
2001,Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2?3?-dideoxycytidine (DDC),"Dalakas M.C., Semino-Mora C., Leon-Monzon M.",236837,Laboratory Investigation,81,11,52,12,12,24,4,80
2001,"Stiff person syndrome: Quantification, specificity, and intrathecal synthesis of GAD65 antibodies","Dalakas M.C., Li M., Fujii M., Jacobowitz D.M.",283878,Neurology,57,5,36,12,10,22,4,62
2001,Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy,"Hughes R., Dalakas M., Bojar M., Swan A., MedSci F., Bensa S., Willison H., Van Bergh P.D., Comi G., Illa I., Nobile-Orazio E., Van Doorn P.",3645134,Annals of Neurology,50,2,133,30,32,62,23,218
2001,The molecular and cellular pathology of inflammatory muscle diseases,Dalakas M.C.,14714892,Current Opinion in Pharmacology,1,3,29,4,4,8,0,37
2001,Progress in inflammatory myopathies: Good but not good enough,Dalakas M.C.,223050,Journal of Neurology Neurosurgery and Psychiatry,70,5,15,3,1,4,0,19
2001,Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations,"Li M., Dalakas M.C.",3645134,Annals of Neurology,49,4,15,1,0,1,0,16
2001,Peripheral neuropathy and antiretroviral drugs,Dalakas M.C.,10859489,Journal of the Peripheral Nervous System,6,1,56,9,4,13,7,76
2001,A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM,"Dalakas M.C., Koffman B., Fujii M., Spector S., Sivakumar K., Cupler E.",283878,Neurology,56,3,59,8,13,21,8,88
2001,MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis,"Abbott G.W., Butler M.H., Bendahhou S., Dalakas M.C., Ptacek L.J., Goldstein S.A.N",928674,Cell,104,2,131,14,8,22,5,158
2000,Desmin splice variants causing cardiac and skeletal myopathy,"Park K.-Y., Dalakas M.C., Goebel H.H., Ferrans V.J., Semino-Mora C., Litvak S., Takeda K., Goldfarb L.G.",222593,Journal of Medical Genetics,37,11,29,6,3,9,3,41
2000,The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome,"Dalakas M.C., Fujii M., Li M., McElroy B.",283878,Neurology,55,10,46,5,10,15,7,68
2000,Motor cortex excitability in stiff-person syndrome,"Sandbrink F., Syed N.A., Fujii M.D., Dalakas M.C., Floeter M.K.",68950,Brain,123,11,21,1,1,2,2,25
2000,Mitochondrial DNA variants in inclusion body myositis,"Kok C.C., Boyt A., Gaudieri S., Martins R., Askanas V., Dalakas M., Kiers L., Mastaglia F., Garlepp M.",9608966,Neuromuscular Disorders,10,8,4,4,0,4,1,9
2000,Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time: Studies in repeated muscle biopsies,"Amemiya K., Granger R.P., Dalakas M.C.",68950,Brain,123,10,30,12,4,16,3,49
2000,Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies,"Merkies I.S.J., Comi G., Dalakas M.C., Hartung H.P., Hughes R.A.C., Illa I., Knapp M.R.J., Lger J.-M., Nemni R., Nobile-Orazio E., Toyka K.V., Schmitz P.I.M., Van De Bergh P., Willison H.J., Younes-Chennoufi B., Samijn J.P.A., Van Der Mech F.G.A., Van Doorn P.A., Aubry J., Baumann N., Bouche",0148639X,Muscle and Nerve,23,9,13,3,11,14,0,27
2000,Lactic acidosis and hepatic steatosis associated with use of stavudine: Report of four cases,"Miller K.D., Cameron M., Wood L.V., Dalakas M.C., Kovacs J.A.",34819,Annals of Internal Medicine,133,3,129,4,5,9,6,144
2000,"Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy","Murata K.-Y., Dalakas M.C.",68950,Brain,123,8,25,1,1,2,0,27
2000,Disease progression in sporadic inclusion body myositis: Observations in 78 patients,"Peng A., Koffman B.M., Malley J.D., Dalakas M.C.",283878,Neurology,55,2,21,5,4,9,2,32
2000,Expression of human IAP-like protein in skeletal muscle: A possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies,"Li M., Dalakas M.C.",1655728,Journal of Neuroimmunology,106, 1-2,30,1,1,2,2,34
2000,Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation,"Park K.-Y., Dalakas M.C., Semino-Mora C., Lee H.-S., Litvak S., Takeda K., Ferrans V.J., Goldfarb L.G.",99163,Clinical Genetics,57,6,24,1,0,1,1,26
2000,The muscle mitogen-activated protein kinase is altered in sporadic inclusion body myositis,"Li M., Dalakas M.C.",283878,Neurology,54,8,10,0,0,0,1,11
2000,"Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene","Dalakas M.C., Park K.-Y., Semino-Mora C., Lee H.S., Sivakumar K., Goldfarb L.G.",284793,New England Journal of Medicine,342,11,153,21,11,32,8,193
2000,Downregulation of TGF-?1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin,"Amemiya K., Semino-Mora C., Granger R.P., Dalakas M.C.",15216616,Clinical Immunology,94,2,49,4,3,7,1,57
2000,Viral hide-and-seek in sporadic ALS: A new challenge,"Karpati G., Dalakas M.C.",283878,Neurology,54,1,15,1,1,2,0,17
2000,Randomized trials of dichlorphenamide in the periodic paralyses,"Tawil R., Hahn A.F., Griggs R.C., McDermott M.P., Brown Jr. R., Shapiro B.C., Ptacek L.J., McManis P.G., Dalakas M.C., Spector S.A., Mendell J.R.",3645134,Annals of Neurology,47,1,31,9,13,22,1,54
2000,Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies,"Choi Y.-C., Dalakas M.C.",283878,Neurology,54,1,53,9,2,11,7,71
2000,"Waldenstrom's macroglobulinemia: Clinical features, complications, and management","Dimopoulos M.A., Panayiotidis P., Moulopoulos L.A., Sfikakis P., Dalakas M.",0732183X,Journal of Clinical Oncology,18,1,125,15,12,27,1,153
1999,Advances in chronic inflammatory demyelinating polyneuropathy: Disease variants and inflammatory response mediators and modifiers,Dalakas M.C.,13507540,Current Opinion in Neurology,12,4,32,0,0,0,0,32
1999,Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines,Dalakas M.C.,0148639X,Muscle and Nerve,22,11,87,9,6,15,1,103
1999,Why drugs fail in postpolio syndrome: Lessons from another clinical trial,Dalakas M.C.,283878,Neurology,53,6,5,0,1,1,0,6
1999,The stiff-person syndrome: An autoimmune disorder affecting neurotransmission of ?-aminobutyric acid,"Levy L.M., Dalakas M.C., Floeter M.K.",34819,Annals of Internal Medicine,131,7,53,5,12,17,5,75
1999,"Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies","Murata K.-Y., Dalakas M.C.",29440,American Journal of Pathology,155,2,45,9,2,11,2,58
1999,Movement-related cerebellar activation in the absence of sensory input,"Weeks R.A., Gerloff C., Honda M., Dalakas M.C., Hallett M.",223077,Journal of Neurophysiology,82,1,7,0,0,0,0,7
1999,Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia,"Weiss M.D., Dalakas M.C., Lauter C.J., Willison H.J., Quarles R.H.",1655728,Journal of Neuroimmunology,95, 1-2,26,4,1,5,0,31
1999,Physiologic events initiating REM sleep in patients with the postpolio syndrome,"Siegel H., McCutchen C., Dalakas M.C., Freeman A., Graham B., Alling D., Sato S.",283878,Neurology,52,3,7,0,1,1,0,8
1999,T-cell apoptosis in inflammatory neuromuscular disorders associated with human immunodeficiency virus infection,"Schneider C., Dalakas M.C., Toyka K.V., Said G., Hartung H.-P., Gold R.",39942,Archives of Neurology,56,1,14,1,0,1,0,15
1999,Updata on sporadic inclusion body myositis,Dalakas M.C.,11282460,Acta Myologica,3, ,0,0,0,0,0,0
1998,"Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis",Dalakas M.C.,283878,Neurology,51,6,55,1,1,2,1,58
1998,The use of intravenous immunoglobulin for neurologic diseases,Dalakas M.C.,283878,Neurology,51,6,9,0,0,0,0,9
1998,Narrowing of the gene locus for autosomal-recessive quadriceps sparing inclusion-body myopathy (ARQS-IBM) to chromosome 9p1,"Christodoulou K., Middleton L.T., Papadopoulou E., Tsingis M., Askanas V., King Engel W., Ferrin J., Dalakas M., Rowland L.P., Mirabella M.",11282460,Acta Myologica,2, ,4,0,0,0,0,4
1998,Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma,"Weiss M.D., Luciano C.A., Semino-Mora C., Dalakas M.C., Quarles R.H.",283878,Neurology,51,6,33,3,2,5,1,39
1998,Molecular immunology and genetics of inflammatory muscle diseases,Dalakas M.C.,39942,Archives of Neurology,55,12,58,6,6,12,6,76
1998,Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases,Dalakas M.C.,283878,Neurology,51,6,76,4,2,6,1,83
1998,Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15,"Sambuughin N., Sivakumar K., Selenge B., Suk Lee H., Friedlich D., Baasanjav D., Dalakas M.C., Goldfarb L.G.",0022510X,Journal of the Neurological Sciences,161,1,29,4,2,6,0,35
1998,Rimmed vacuoles with ?-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): Similarities with inclusion body myositis,"Semino-Mora C., Dalakas M.C.",468177,Human Pathology,29,10,22,5,3,8,2,32
1998,Missense mutations in desmin associated with familial cardiac and skeletal myopathy,"Goldfarb L.G., Dalakas M.C., Park K.-Y., Cervenakova L., Gorokhova S., Lee H.S., Vasconcelos O., Nagle J.W., Semino-Mora C., Sivakumar K.",10614036,Nature Genetics,19,4,202,22,12,34,12,248
1998,Normal postexercise facilitation and depression of motor evoked potentials in postpolio patients,"Samii A., Lopez-Devine J., Wasserman E.M., Dalakas M.C., Clark K., Grafman J., Hallett M.",0148639X,Muscle and Nerve,21,7,7,0,2,2,0,9
1998,Sleep apnea in patients with postpolio syndrome,"Dean A.C., Graham B.A., Dalakas M., Sato S.",3645134,Annals of Neurology,43,5,17,1,2,3,1,21
1998,HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies,"Koffman B.M., Sivakumar K., Simonis T., Stroncek D., Dalakas M.C.",1655728,Journal of Neuroimmunology,84,2,30,5,3,8,3,41
1998,"Fatigue: Definitions, mechanisms, and paradigms for study","Dalakas M.C., Mock V., Hawkins M.J.",937754,Seminars in Oncology,25,1,31,4,0,4,0,35
1998,Skeletal muscle-specific immunotoxin for the treatment of focal muscle spasm,"Hott J.S., Dalakas M.C., Sung C., Hallett M., Youle R.J.",283878,Neurology,50,2,14,1,1,2,1,17
1998,Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis,"Koffman B.M., Rugiero M., Dalakas M.C.",0148639X,Muscle and Nerve,21,1,47,6,3,9,3,59
1998,"Dermatomyositis, polymyositis and inclusion body myositis: current concepts.","Illa I., Dalakas M.C.",353787,Revue neurologique,154,1,4,0,1,1,1,6
1997,Meningitis and skin reaction after intravenous immune globulin therapy [3] (multiple letters),"Gabor E.P., Catteau B., Delaporte E., Piette F., Dalakas M.C.",34819,Annals of Internal Medicine,127,12,13,0,0,0,1,14
1997,Inclusion body myositis and myopathies,"Sivakumar K., Dalakas M.C.",13507540,Current Opinion in Neurology,10,5,25,0,1,1,2,28
1997,Safety and efficacy of strength training in patients with sporadic inclusion body myositis,"Spector S.A., Lemmer J.T., Koffman B.M., Fleisher T.A., Feuerstein I.M., Hurley B.F., Dalakas M.C.",0148639X,Muscle and Nerve,20,10,34,11,1,12,6,52
1997,A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system,"Castelli J.C., Hassel B.A., Wood K.A., Li X.-L., Amemiya K., Dalakas M.C., Torrence P.F., Youle R.J.",221007,Journal of Experimental Medicine,186,6,116,17,3,20,2,138
1997,"Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: Assessments based on controlled treatment trials in patients with neurological diseases","Koffman B.M., Dalakas M.C.",0148639X,Muscle and Nerve,20,9,33,2,2,4,2,39
1997,Intravenous immune globulin therapy for neurologic diseases,Dalakas M.C.,34819,Annals of Internal Medicine,126,9,158,5,8,13,5,176
1997,"An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families","Sivakumar K., Semino-Mora C., Dalakas M.C.",68950,Brain,120,4,28,4,4,8,2,38
1997,Experience with IVIg in the treatment of patients with myasthenia gravis,Dalakas M.C.,283878,Neurology,48,4,17,2,0,2,0,19
1997,Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis,"Sekul E.A., Chow C., Dalakas M.C.",283878,Neurology,48,4,23,4,6,10,2,35
1997,Mitochondrial and cellular toxicity induced by Fialuridine in human muscle in vitro,"Semino-Mora C., Leon-Monzon M., Dalakas M.C.",236837,Laboratory Investigation,76,4,9,1,1,2,1,12
1997,"Treatment of inclusion-body myositis with IVIg: A double-blind, placebo- controlled study","Dalakas M.C., Sonies B., Dambrosia J., Sekul E., Cupler E., Sivakumar K.",283878,Neurology,48,3,96,12,14,26,6,128
1997,Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlations,"Dalakas M.C., Illa I., Gallardo E., Juarez C.",3645134,Annals of Neurology,41,1,14,5,3,8,1,23
1997,Inclusion body myositis: No evidence for a neurogenic component,"Luciano C.A., Dalakas M.C.",283878,Neurology,48,1,24,5,1,6,1,31
1996,Inclusion body myositis in HIV-1 and HTLV-1 infected patients,"Cupler E.J., Leon-Monzon M., Miller J., Semino-Mora C., Anderson T.L., Dalakas M.C.",68950,Brain,119,6,48,6,6,12,3,63
1996,"Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barre syndrome, myasthenia gravis and dermatomyositis","Basta M., Illa I., Dalakas M.C.",1655728,Journal of Neuroimmunology,71, 1-2,19,1,1,2,0,21
1996,"MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis","Schneider C., Gold R., Dalakas M.C., Schmied M., Lassmann H., Toyka K.V., Hartung H.-P.",223069,Journal of Neuropathology and Experimental Neurology,55,12,58,6,1,7,1,66
1996,A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy,"Dalakas M.C., Quarles R.H., Farrer R.G., Dambrosia J., Soueidan S., Stein D.P., Cupler E., Sekul E.A., Otero C.",3645134,Annals of Neurology,40,5,74,8,7,15,4,93
1996,Electrophysiologic and histologic studies in clinically unaffected muscles of patients with prior paralytic poliomyelitis,"Luciano C.A., Sivakumar K., Spector S.A., Dalakas M.C.",0148639X,Muscle and Nerve,19,11,15,1,0,1,1,17
1996,The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews,"Sivakumar K., Dalakas M.C.",283878,Neurology,47,4,38,3,0,3,4,45
1996,Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy,"Spector S.A., Gordon P.L., Feuerstein I.M., Sivakumar K., Hurley B.F., Dalakas M.C.",0148639X,Muscle and Nerve,19,10,16,3,0,3,0,19
1996,Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals,"Cupler E.J., Otero C., Hench K., Luciano C., Dalakas M.C.",0148639X,Muscle and Nerve,19,9,4,0,1,1,0,5
1996,Is hereditary inclusion body myopathy a 'familial prion disease'? [1],"Cervenakova L., Sivakumar K., Nagle J., Dalakas M.C., Goldfarb L.G.",3645134,Annals of Neurology,40,1,1,1,0,1,0,2
1996,"The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis","Dalakas M.C., Sivakumar K.",13507540,Current Opinion in Neurology,9,3,26,1,2,3,1,30
1996,Neuropathies in HIV infection,"Dalakas M.C., Cupler E.J.",9610421,Bailliere's Clinical Neurology,5,1,22,1,1,2,1,25
1996,Autoimmune ataxic neuropathies (sensory ganglionopathies): Are glycolipids the responsible autoantigens?,"Dalakas M.C., Quarles R.H.",3645134,Annals of Neurology,39,4,36,1,1,2,1,39
1996,Multiple antibodies to nerve glycoconjugates in a patient with neuropathy and monoclonal IgA gammopathy,"Farrer R.G., Dalakas M.C., Quarles R.H.",1655728,Journal of Neuroimmunology,66, 1-2,2,0,0,0,0,2
1996,Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle,"Poetter K., Epstein N.D., Jiang H., Hassanzadeh S., Master S.R., Chang A., Dalakas M.C., Rayment I., Sellers J.R., Fananapazir L.",10614036,Nature Genetics,13,1,257,9,14,23,13,293
1996,"Late-onset muscle weakness in partial phosphofructokinase deficiency: A unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation","Sivakumar K., Vasconcelos O., Goldfarb L., Dalakas M.C.",283878,Neurology,46,5,10,1,0,1,0,11
1996,Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome,"Goldstein D.S., McRae A., Holmes C., Dalakas M.C.",9599851,Clinical Autonomic Research,6,1,4,0,0,0,0,4
1996,Clinical benefits and immunopathological correlates of intravenous immune globulin in the treatment of inflammatory myopathies,Dalakas M.C.,9642536,"Clinical and Experimental Immunology, Supplement",104,1,24,1,0,1,1,26
1996,Do anti-ganglioside antibodies cause human peripheral neuropathies?,"Quarles R.H., Dalakas M.C.",219738,The Journal of clinical investigation,97,5,6,0,0,0,1,7
1995,Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease,"Vasconcelos O., Sivakumar K., Dalakas M.C., Quezado M., Nagle J., Leon-Monzon M., Dubnick M., Gajdusek D.C., Goldfarb L.G.",278424,Proceedings of the National Academy of Sciences of the United States of America,92,22,6,0,0,0,0,6
1995,Expression of poliovirus receptor in human spinal cord and muscle,"Leon-Monzon M.E., Illa I., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,9,0,0,0,1,10
1995,Reinnervation in clinically unaffected muscles of patients with prior paralytic poliomyelitis. Correlation between macroelectromyography and histology,"Luciano C.A., Sivakumar K., Spector S.A., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,0,0,0,0,0,0
1995,Effect of strength training in patients with post-polio syndrome. A preliminary report,"Spector S.A., Gordon P.L., Yildiz E., Sivakumar K., Hurley B.F., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,3,0,0,0,0,3
1995,Neuropsychology of post-polio syndrome,"Grafman J., Clark K., Richardson D., Dinsmore S., Stein D., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,8,0,0,0,0,8
1995,Antiganglioside antibodies in patients with acute polio and post-polio syndrome,"Illa I., Leon-Monzon M., Agboatwalla M., Ilyas A., Latov N., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,4,1,0,1,0,5
1995,Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome,"Leon-Monzon M.E., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,17,4,4,8,0,25
1995,How to design a therapeutic study in patients with the post-polio syndrome. Methodological concerns and status of present therapies,Dalakas M.C.,778923,Annals of the New York Academy of Sciences,753, ,3,0,1,1,1,5
1995,Progression of oral-motor and swallowing symptoms in the post-polio syndrome,"Sonies B.C., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,10,0,0,0,0,10
1995,Post-polio syndrome in twins and their siblings. Evidence that post-polio syndrome can develop in patients with nonparalytic polio,"Nee L., Dambrosia J., Bern E., Eldridge R., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,7,0,0,0,0,7
1995,"A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome","Dinsmore S., Dambrosia J., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,17,3,0,3,1,21
1995,Cellular localization of poliovirus RNA in the spinal cord during acute paralytic poliomyelitis,"Isaacson S.H., Sivakumar K., Asher D.M., Pomeroy K.L., Ramos-Alvarez M., Gibbs Jr. C.J., Gajdusek D.C., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,7,0,1,1,0,8
1995,Concluding remarks and future strategies,"Dalakas M.C., Bartfeld H., Kurland L.T.",778923,Annals of the New York Academy of Sciences,753, ,0,0,0,0,0,0
1995,"Pathogenetic mechanisms of post-polio syndrome: Morphological, electrophysiological, virological, and immunological correlations",Dalakas M.C.,778923,Annals of the New York Academy of Sciences,753, ,41,2,0,2,2,45
1995,"A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome","Stein D.P., Dambrosia J.M., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,20,3,2,5,0,25
1995,The post-polio syndrome as an evolved clinical entity. Definition and clinical description,Dalakas M.C.,778923,Annals of the New York Academy of Sciences,753, ,63,5,3,8,3,74
1995,Post-polio syndrome 12 years later. How it all started,Dalakas M.C.,778923,Annals of the New York Academy of Sciences,753, ,9,0,0,0,0,9
1995,Role of the muscle in acute poliomyelitis infection,"Illa I., Leon-Monzon M., Agboatwalla M., Dure-Samin A., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,4,0,0,0,0,4
1995,The cup T-cell receptor repertoire in idiopathic inflammatory myopathies: Distinct patterns of gene expression by muscle-infiltrating lymphocytes in different clinical and serologic groups,"O'Hanlon T.P., Dalakas M.C., Plotz P.H., Miller F.W.",778923,Annals of the New York Academy of Sciences,756, ,1,0,0,0,0,1
1995,Images in clinical medicine. Calcifications in dermatomyositis.,Dalakas M.C.,284793,New England Journal of Medicine,333,15,0,0,0,0,0,0
1995,Acute axonal Guillain-Barre syndrome with IgG antibodies against motor axons following parenteral gangliosides,"Illa I., Ortiz N., Gallard E., Juarez C., Grau J.M., Dalakas M.C.",3645134,Annals of Neurology,38,2,83,3,2,5,5,93
1995,Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy,"Sivakumar K., Cervenakova L., Dalakas M.C., Leon-Monzon M., Isaacson S.H., Nagle J.W., Vasconcelos O., Goldfarb L.G.",3645134,Annals of Neurology,38,2,4,3,0,3,1,8
1995,Common variable immunodeficiency and inclusion body myositis: A distinct myopathy mediated by natural killer cells,"Dalakas M.C., Illa I.",3645134,Annals of Neurology,37,6,17,4,1,5,1,23
1995,Immunopathogenesis of inflammatory myopathies,Dalakas M.C.,3645134,Annals of Neurology,37,1,104,5,5,10,3,117
1995,Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: Present and future prospects,Dalakas M.C.,3645134,Annals of Neurology,37,1,37,0,1,1,0,38
1995,Identification of macrophages in the muscle biopsy preparations: A comparative study using specific monoclonal antimacrophage antibodies and acid phosphatase reaction,"Drosos A.A., Dalakas M.C.",0148639X,Muscle and Nerve,18,2,4,1,0,1,0,5
1995,?? T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies,"O'Hanlon T.P., Messersmith W.A., Dalakas M.C., Plotz P.H., Miller F.W.",99104,Clinical and Experimental Immunology,100,3,6,1,0,1,1,8
1995,Clinical neuroimmunology and immunotherapy: Introduction,Dalakas M.C.,3645134,Annals of Neurology,37,1,0,0,0,0,0,0
1995,Study of fatigue in muscles of patients with post-polio syndrome by in vivo [31P]magnetic resonance spectroscopy. A metabolic cause for fatigue,"Sivakumar K., Sinnwell T., Yildiz E., McLaughlin A., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,753, ,9,1,0,1,0,10
1995,Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease,Dalakas M.C.,2719142,Journal of Clinical Immunology,15,6,16,1,0,1,3,20
1995,Early features of zidovudine-associated myopathy: Histopathological findings and clinical correlations,"Cupler E.J., Danon M.J., Jay C., Hench K., Ropka M., Dalakas M.C.",16322,Acta Neuropathologica,90,1,32,2,2,4,1,37
1995,Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin,"Bitton R.J., Figg W.D., Venzon D.J., Dalakas M.C., Bowden C., Headlee D., Reed E., Myers C.E., Cooper M.R.",0732183X,Journal of Clinical Oncology,13,9,25,2,2,4,1,30
1995,Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy,"Sinnwell T.M., Sivakumar K., Soueidan S., Jay C., Frank J.A., McLaughlin A.C., Dalakas M.C.",219738,Journal of Clinical Investigation,96,1,30,2,1,3,0,33
1995,Mitochondrial toxicity of antiviral drugs,"Lewis W., Dalakas M.C.",10788956,Nature Medicine,1,5,381,35,20,55,17,453
1995,Aseptic meningitis and intravenous immunoglobulin therapy [3],"Harati Y., Aziz Taher Shaibani, Peetermans W.E., Van Wijngaerden E., Knockaert D.C., Dalakas M.C.",34819,Annals of Internal Medicine,122,4,12,0,0,0,0,12
1995,Exacerbation of peripheral neuropathy by lamivudine [23],"Cupler E.J., Dalakas M.C.",1406736,Lancet,345,8947,13,0,1,1,0,14
1995,Intramuscular injections and vaccine-associated poliomyelitis [1],"Dalakas M.C., Pallansch M.A., Cochi S.L., Illa I., Leon-Monzon M., Ross R.T., Weinberg R.J., Rustioni A., Sepkowitz S., Strebel P.M., Sutter R.W.",284793,New England Journal of Medicine,333,1,5,0,0,0,0,5
1994,Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors,"Sekul E.A., Cupler E.J., Dalakas M.C.",34819,Annals of Internal Medicine,121,4,151,17,8,25,3,179
1994,Current treatment of the inflammatory myopathies,Dalakas M.C.,10408711,Current Opinion in Rheumatology,6,6,43,2,1,3,1,47
1994,High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments,"Basta M., Dalakas M.C.",219738,Journal of Clinical Investigation,94,5,182,9,11,20,1,203
1994,A personality profile of patients diagnosed with post-polio syndrome,"Clark K., Dinsmore S., Grafman J., Dalakas M.C.",283878,Neurology,44,10,10,0,1,1,1,12
1994,Polymyositis in patients infected with human T-cell leukemia virus type I: The role of the virus in the cause of the disease,"Leon-Monzon M., Illa I., Dalakas M.C.",3645134,Annals of Neurology,36,4,46,3,1,4,0,50
1994,Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage,"Dalakas M.C., Leon-Monzon M.E., Bernardini I., Gahl W.A., Jay C.A.",3645134,Annals of Neurology,35,4,61,1,3,4,2,67
1994,High-dose intravenous immunoglobulin and serum viscosity: Risk of precipitating thromboembolic events,Dalakas M.C.,283878,Neurology,44,2,121,11,5,16,7,144
1994,Distal vacuolar myopathy in nephropathic cystinosis,"Charnas L.R., Gahl W.A., Luciano C.A., Dalakas M., Gilliatt R.W., Bernardini I., Ishak K., Cwik V.A., Fraker D., Brushart T.A.",3645134,Annals of Neurology,35,2,33,1,4,5,0,38
1994,Autoimmune syndrome induced by omeprazole [17],"Sivakumar K., Dalakas M.C.",1406736,Lancet,344,8922,9,0,0,0,0,9
1994,How to diagnose and treat the inflammatory myopathies,Dalakas M.C.,2718235,Seminars in Neurology,14,2,6,2,0,2,0,8
1994,Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro,"Semino-Mora M.C., Leon-Monzon M.E., Dalakas M.C.",236837,Laboratory Investigation,71,1,32,0,2,2,1,35
1994,Muscle carnitine deficiency associated with zidovudine-induced mitochondrial myopathy [3],"Campos Y., Arenas J., Dalakas M.C.",3645134,Annals of Neurology,36,4,2,0,0,0,0,2
1994,The ?? T-cell receptor repertoire in inclusion body myositis: Diverse patterns of gene expression by muscle-infiltrating lymphocytes,"O'Hanlon T.P., Dalakas M.C., Plotz P.H., Miller F.W.",8968411,Journal of Autoimmunity,7,3,24,0,0,0,0,24
1994,"The drugs 2',3'-dideoxyinosine (ddI) and 2',3'-dideoxycytidine (ddC) are safe alternatives in people with AIDS with zidovudine-induced myopathy [4]","Jay C., Ropka M., Dalakas M.C.",8949255,Journal of Acquired Immune Deficiency Syndromes,7,6,6,0,0,0,0,6
1994,Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy,"Dalakas M.C., Stein D.P., Otero C., Sekul E., Cupler E.J., McCrosky S.",39942,Archives of Neurology,51,9,34,2,0,2,0,36
1994,Predominant TCR-?? variable and joining gene expression by muscle- infiltrating lymphocytes in the idiopathic inflammatory myopathies,"O'Hanlon T.P., Dalakas M.C., Plotz P.H., Miller F.W.",221767,Journal of Immunology,152,5,53,7,0,7,0,60
1994,Neuroimmunotherapy: A practical approach to the treatment of immune- mediated neurologic diseases,Dalakas M.C.,2718235,Seminars in Neurology,14,2,6,0,0,0,0,6
1994,HIV or zidovudine myopathy? [2],"Dalakas M., Godbold J., Wolfe D.E., Kieburtz K., Grau J.M., Casademont J., Gherardi R., Chariot P., Simpson D.M., Citak K., Godfrey E.",283878,Neurology,44,2,4,0,0,0,0,4
1994,The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction,"Semino-Mora M.C., Leon-Monzon M.E., Dalakas M.C.",236837,Laboratory Investigation,71,5,37,1,3,4,0,41
1994,Intravenous immune globulin for dermatomyositis [6],"Brownell A.K.W., Dalakas M.C.",284793,New England Journal of Medicine,330,19,7,0,1,1,0,8
1993,A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis,"Dalakas M.C., Illa I., Dambrosia J.M., Soueidan S.A., Stein D.P., Otero C., Dinsmore S.T., McCrosky S.",284793,New England Journal of Medicine,329,27,361,34,22,56,18,435
1993,Retroviruses and inflammatory myopathies in humans and primates.,Dalakas M.C.,9610421,"Bailliere""s clinical neurology",2,3,17,0,1,1,0,18
1993,Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan,"Illa I., Dinsmore S., Dalakas M.C.",468177,Human Pathology,24,7,9,1,0,1,1,11
1993,Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin,"Soueidan S.A., Dalakas M.C.",283878,Neurology,43,5,58,3,2,5,2,65
1993,Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin,"Soueidan S.A., Dalakas M.C., Schwartz, Levinson A.",313998,Pediatric Research,33,1,14,1,2,3,0,17
1993,Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis,"Gahl W.A., Bernardini I.M., Dalakas M.C., Markello T.C., Krasnewich D.M., Charnas L.R.",313998,Pediatric Research,34,2,7,0,1,1,0,8
1993,Myopathies and retrovirus | MIOPATIAS Y RETROVIRUS,"Illa I., Monzon M., Dalakas M.C.",3044815,Revista Espanola de Reumatologia,20,8,0,0,0,0,0,0
1993,Missense mutations in the ?-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy,"Fananapazir L., Dalakas M.C., Cyran F., Cohn G., Epstein N.D.",278424,Proceedings of the National Academy of Sciences of the United States of America,90,9,84,7,8,15,3,102
1993,Inclusion body myositis: New concepts,"Sekul E.A., Dalakas M.C.",2718235,Seminars in Neurology,13,3,45,2,3,5,1,51
1993,Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis,"Leon-Monzon M., Lamperth L., Dalakas M.C.",0148639X,Muscle and Nerve,16,4,22,2,1,3,1,26
1992,Elevated creatine kinase level in postpolio syndrome,"Taylor T.E., Dalakas M.C.",987484,Journal of the American Medical Association,268,22,2,1,0,1,0,3
1992,Parenchymal organ cystine depletion with long-term cysteamine therapy,"Gahl W.A., Charnas L., Markello T.C., Bernardini I., Ishak K.G., Dalakas M.C.",8854505,Biochemical Medicine and Metabolic Biology,48,3,27,3,4,7,0,34
1992,Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside,"Daune G.C., Farrer R.G., Dalakas M.C., Quarles R.H.",3645134,Annals of Neurology,31,6,48,1,2,3,0,51
1992,Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle,"Leff R.L., Love L.A., Miller F.W., Greenberg S.J., Klein E.A., Dalakas M.C., Plotz P.H.",1406736,Lancet,339,8803,45,5,1,6,3,54
1992,Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies,"Leon-Monzon M., Dalakas M.C.",3645134,Annals of Neurology,32,2,17,2,2,4,0,21
1992,Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis,"Miller F.W., Leitman S.F., Cronin M.E., Hicks J.E., Leff R.L., Wesley R., Fraser D.D., Dalakas M., Plotz P.H.",284793,New England Journal of Medicine,326,21,104,13,6,19,2,125
1992,"Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies",Dalakas M.C.,3625664,Clinical Neuropharmacology,15,5,36,0,1,1,1,38
1992,"Polymyositis, dermatomyositis and inclusion-body hyositis | POLYMYOSITIS, DERMATOMYOSITIS UND EINSCHLUSSKORPERCHENMYOSITIS",Dalakas M.C.,0341051X,Aktuelle Rheumatologie,17,1,0,0,0,0,0,0
1992,Inflammatory and toxic myopathies,Dalakas M.C.,9517383,Current Opinion in Neurology and Neurosurgery,5,5,19,0,0,0,3,22
1992,Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide,"Ilyas A.A., Cook S.D., Dalakas M.C., Mithen F.A.",1655728,Journal of Neuroimmunology,37, 1-2,25,2,2,4,0,29
1992,Polymyositis [5],"Hohlfeld R., Engel A.G., Dalakas M.C.",284793,New England Journal of Medicine,326,19,3,0,0,0,0,3
1992,Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells,"Illa I., Leon-Monzon M., Dalakas M.C.",3645134,Annals of Neurology,31,1,62,6,5,11,4,77
1991,Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies,"Pezeshkpour G., Illa I., Dalakas M.C.",468177,Human Pathology,22,12,36,0,1,1,0,37
1991,Antibodies to acidic glycolipids in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy,"Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.-W., Cook S.D.",0022510X,Journal of the Neurological Sciences,107,1,72,1,0,1,0,73
1991,Magnetic resonance imaging in the idiopathic inflammatory myopathies,"Fraser D.D., Frank J.A., Dalakas M., Miller F.W., Hicks J.E., Plotz P.",0315162X,Journal of Rheumatology,18,11,71,4,3,7,2,80
1991,A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups,"Love L.A., Leff R.L., Fraser D.D., Targoff I.N., Dalakas M., Plotz P.H., Miller F.W.",257974,Medicine,70,6,255,37,23,60,21,336
1991,Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model,"Lamperth L., Dalakas M.C., Dagani F., Anderson J., Ferrari R.",236837,Laboratory Investigation,65,6,73,4,4,8,2,83
1991,Antibodies to sulfated glycolipids in Guillain-Barre syndrome,"Ilyas A.A., Mithen F.A., Dalakas M.C., Wargo M., Chen Z.-W., Bielory L., Cook S.D.",0022510X,Journal of the Neurological Sciences,105,1,32,1,0,1,0,33
1991,Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy,"Arnaudo E., Dalakas M., Shanske S., Moraes C.T., DiMauro S., Schon E.A.",1406736,Lancet,337,8740,238,12,11,23,3,264
1991,"Post-polio syndrome: concepts in clinical diagnosis, pathogenesis, and etiology.","Dalakas M., Illa I.",913952,Advances in neurology,56, ,24,1,1,2,1,27
1991,Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: Similarities with seronegative polymyositis,"Illa I., Nath A., Dalakas M.",3645134,Annals of Neurology,29,5,44,5,4,9,2,55
1991,[324] Studies in neuromuscular and CNS diseses and their experimental models,Dalakas M.C.,0007506X,Journal of Rehabilitation Research and Development,28,1,0,0,0,0,0,0
1991,Inflammatory myopathies: MR imaging and spectroscopy,"Fraser D.D., Frank J.A., Dalakas M.C.",338419,Radiology,179,2,11,0,1,1,0,12
1991,Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies,"Leff R.L., Burgess S.H., Miller F.W., Love L.A., Targoff I.N., Dalakas M.C., Joffe M.M., Plotz P.H.",43591,Arthritis and Rheumatism,34,11,24,2,5,7,3,34
1991,Dysphagia in the post-polio syndrome [5],"Heimlich H.J., Schmutzhard E., Kraft S., Berek K., Pfausler B., Willeit J., Parsons P.E., Dalakas M.C.",284793,New England Journal of Medicine,325,15,3,0,0,0,0,3
1991,"Medical progress: Polymyositis, dermatomyositis, and inclusion-body myositis",Dalakas M.C.,284793,New England Journal of Medicine,325,21,406,38,20,58,14,478
1991,Dysphagia in patients with the post-polio syndrome,"Sonies B.C., Dalakas M.C.",284793,New England Journal of Medicine,324,17,29,0,0,0,0,29
1990,Postpolio syndrome,Dalakas M.,10408711,Current Opinion in Rheumatology,2,6,7,0,0,0,0,7
1990,Clinical and electromyographic studies of postpoliomyelitis muscular atrophy,"Ravits J., Hallett M., Baker M., Nilsson J., Dalakas M.",0148639X,Muscle and Nerve,13,8,22,1,0,1,0,23
1990,Single skinned muscle fibers in Duchenne muscular dystrophy generate normal force,"Horowits R., Dalakas M.C., Podolsky R.J.",3645134,Annals of Neurology,27,6,5,1,1,2,0,7
1990,Acquired immunodeficiency syndrome and the nervous system (I: Reply),Dalakas M.,987484,Journal of the American Medical Association,263,1,0,0,0,0,0,0
1990,High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy,"Cook D., Dalakas M., Galdi A., Biondi D., Porter H.",283878,Neurology,40,2,52,1,2,3,0,55
1990,Inflammatory myopathies,Dalakas M.,9517383,Current Opinion in Neurology and Neurosurgery,3,5,1,0,0,0,0,1
1990,Suramin-induced polyneuropathy,"La Rocca R.V., Meer J., Gilliatt R.W., Stein C.A., Cassidy J., Myers C.E., Dalakas M.C.",283878,Neurology,40,6,51,2,2,4,0,55
1990,Mitochondrial myopathy caused by long-term zidovudine therapy (I: Reply),"Dalakas M., Illa I.",284793,New England Journal of Medicine,323,14,0,0,0,0,0,0
1990,L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat,"Crofford L.J., Gold P.W., Illa I., Smith C., Sternberg E.M., Rader J.I., Dalakas M.C., Hill Jr. R.H., Page S.W., Needham L.L., Brady L.S., Heyes M.P., Wilder R.L.",219738,Journal of Clinical Investigation,86,5,20,0,1,1,0,21
1990,Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases,Dalakas M.,7338619,Neurologic Clinics,8,1,5,0,1,1,0,6
1990,Oligoclonal bands in the cerebrospinal fluid of post-poliomyelitis muscular atrophy (I),Dalakas M.,3645134,Annals of Neurology,28,2,0,0,0,0,0,0
1990,Mitochondrial myopathy caused by long-term zidovudine therapy,"Dalakas M.C., Illa I., Pezeshkpour G.H., Laukaitis J.P., Cohen B., Griffin J.L.",284793,New England Journal of Medicine,322,16,324,23,20,43,10,377
1990,Acute transverse myelitis in systemic lupus erythematosus: Magnetic resonance imaging and review of the literature,"Boumpas D.T., Patronas N.J., Dalakas M.C., Hakim C.A., Klippel J.H., Balow J.E.",0315162X,Journal of Rheumatology,17,1,54,2,3,5,2,61
1989,Treatment of polymyositis and dermatomyositis,Dalakas M.,10408711,Current Opinion in Rheumatology,1,4,11,0,2,2,2,15
1989,"Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders","Plotz P.H., Dalakas M., Leff R.L., Love L.A., Miller F.W., Cronin M.E.",34819,Annals of Internal Medicine,111,2,96,5,3,8,4,108
1989,AIDS and the nervous system,"Dalakas M., Wichman A., Sever J.",987484,Journal of the American Medical Association,261,16,5,0,0,0,0,5
1989,The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy,"Cronin M.E., Miller F.W., Hicks J.E., Dalakas M., Plotz P.H.",0315162X,Journal of Rheumatology,16,9,33,4,1,5,0,38
1989,Localization of immunoreactivre thymosin ?1 in astrocytes of normal human brain,"Su Y.-L., Ho K.L., Dalakas M.C., Mutchnick M.G.",3645134,Annals of Neurology,26,2,11,2,0,2,1,14
1989,"Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC)","Dubinsky R.M., Yarchoan R., Dalakas M., Broder S.",0148639X,Muscle and Nerve,12,10,46,1,4,5,0,51
1988,Cardiac amyloidosis.,Dalakas M.C.,284793,New England Journal of Medicine,318,10,0,0,0,0,0,0
1988,"Antibody to human and simian retrovirus, HTLV-I, HTLV-II, HIV, STLV-III and SRV-I not increased in patients with multiple sclerosis","Madden D.L., Mundon F.K., Tzan N.R., Fuccillo D.A., Dalakas M.C., Calabrese V., Elizan T.S., Roman G.C., Sever J.L.",3645134,Annals of Neurology,23, ,0,0,0,0,0,0
1988,Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis,"Gahl W.A., Hutchison H.T., Dalakas M.C., Charnas L., Chen K.T.K., Pezeshkpour G.H., Kuwabara T., Davis S.L., Chesney R.W., Fink J.",284793,New England Journal of Medicine,319,22,29,2,4,6,2,37
1988,Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: A PET study,"Hatazawa J., Brooks R.A., Dalakas M.C., Mansi L., Di Chiro G.",3638715,Journal of Computer Assisted Tomography,12,4,19,1,3,4,1,24
1988,Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome,"Gahl W.A., Bernardini I., Dalakas M., Rizzo W.B., Harper G.S., Hoeg J.M., Hurko O., Bernar J.",219738,Journal of Clinical Investigation,81,2,6,0,0,0,0,6
1988,Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy,"Ilyas A.A., Willison H.J., Dalakas M.C., Whitaker J.N., Quarles R.H.",223042,Journal of Neurochemistry,51,3,18,1,0,1,1,20
1988,"Tropical spastic paraparesis: Clinical, immunological, and virological studies in two patients from Martinique","Dalakas M.C., Stone G., Elder G., Ceroni M., Madden D., Roman G., Sever J.L.",3645134,Annals of Neurology,23, ,3,0,0,0,0,3
1988,"Treatment of human immunodeficiency virus-related polyneuropathy with 3'-azido-2',3'-dideoxythymidine","Dalakas M.C., Yarchoan R., Spitzer R., Elder G., Sever J.L.",3645134,Annals of Neurology,23, ,5,0,0,0,0,5
1988,"Gangliosides G(M2), IV4GalNAcG(M1b), and IV4GalNAcG(D1a) as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy","Ilyas A.A., Li S.-C., Chou D.K.H., Li Y.-T., Jungalwala F.B., Dalakas M.C., Quarles R.H.",219258,Journal of Biological Chemistry,263,9,27,1,0,1,1,29
1988,Long-term changes in the spinal cords of patients with old poliomyelitis. Signs of continuous disease activity,"Pezeshkpour G.H., Dalakas M.C.",39942,Archives of Neurology,45,5,19,4,1,5,1,25
1988,MRI findings and peripheral neuropathy in Lowe's syndrome,"Charnas L., Bernar J., Pezeshkpour G.H., Dalakas M., Harper G.S., Gahl W.A.",0174304X,Neuropediatrics,19,1,5,1,0,1,2,8
1988,Morphologic changes in the muscles of patients with postpoliomyelitis neuromuscular symptoms,Dalakas M.C.,283878,Neurology,38,1,27,3,1,4,3,34
1988,Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies,"Willison H.J., Trapp B.D., Bacher J.D., Dalakas M.C., Griffin J.W., Quarles R.H.",0148639X,Muscle and Nerve,11,11,35,1,2,3,1,39
1988,"Follow-up of neuropathy from 2',3'-dideoxycytidine","Dubinsky R.M., Dalakas M., Yarchoan R., Broder S.",1406736,Lancet,1,8589,2,0,0,0,0,2
1988,Neuromuscular diseases associated with human immunodeficiency virus infection,"Dalakas M.C., Pezeshkpour G.H.",3645134,Annals of Neurology,23, ,65,5,2,7,3,75
1988,"Serologic studies of MS patients, controls, and patients with other neurologic diseases: Antibodies to HTLV-I, II, III","Madden D.L., Mundon F.K., Tzan N.R., Fuccillo D.A., Dalakas M.C., Calabrese V., Elizan T.S., Sever J.L.",283878,Neurology,38,1,1,0,0,0,0,1
1988,"Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease","Yarchoan R., Klecker R.W., Buchbinder A., Tay S., Larson S.M., Myers C.E., Broder S., Thomas R.V., Grafman J., Wichman A., Dalakas M., McAtee N., Berg G., Fischl M., Perno C.F.",3645134,Annals of Neurology,23, ,10,0,1,1,0,11
1987,Progressive nemaline (rod) myopathy associated with HIV infection,"Dalakas M.C., Pezeshkpour G.H., Flaherty M.",284793,New England Journal of Medicine,317,25,23,0,5,5,1,29
1987,The role of thymosin ?4 and interdigitating cells in the thymic involvement of myasthenia gravis,Dalakas M.C.,778923,Annals of the New York Academy of Sciences,505, ,1,0,0,0,0,1
1987,Lowered cerebral glucose utilization in amyotrophic lateral sclerosis,"Dalakas M.C., Hatazawa J., Brooks R.A., Di Chiro G.",3645134,Annals of Neurology,22,5,31,3,2,5,1,37
1987,Morphological changes of an inflammatory myopathy in rhesus monkeys with simian acquired immunodeficiency syndrome.,"Dalakas M.C., Gravell M., London W.T., Cunningham G., Sever J.L.",379727,Proceedings of the Society for Experimental Biology and Medicine,185,4,4,1,0,1,0,5
1987,Prednisone-responsive limb-girdle syndrome: A special disorder?,"Dalakas M.C., Engel W.K.",0174304X,Neuropediatrics,18,2,0,1,0,1,0,1
1987,Pathology of spinal cord in post-poliomyelitis muscular atrophy.,"Pezeshkpour G.H., Dalakas M.C.",5476844,Birth defects original article series,23,4,6,0,0,0,1,7
1987,Amyotrophic lateral sclerosis and post-polio: differences and similarities.,Dalakas M.C.,5476844,Birth defects original article series,23,4,3,0,0,0,0,3
1987,"New neuromuscular symptoms after old polio (""the post-polio syndrome""): clinical studies and pathogenetic mechanisms.",Dalakas M.C.,5476844,Birth defects original article series,23,4,4,0,0,0,0,4
1987,Peripheral neuropathy and light chain myeloma: case report.,"Elder G., Dalakas M.C., Papadopoulos N., Sever J.L.",283878,Neurology,37,1,0,0,0,0,0,0
1986,Ataxic neuropathy due to ganglioneuronitis after probable acute human immunodeficiency virus infection,"Elder G., Dalakas M., Pezeshkpour G., Sever J.",1406736,Lancet,2,8518,11,1,1,2,0,13
1986,Polymyositis associated with AIDS retrovirus,"Dalakas M.C., Pezeshkpour G.H., Gravell M., Sever J.L.",987484,Journal of the American Medical Association,256,17,54,5,3,8,1,63
1986,New neuromuscular symptoms in patients with old poliomyelitis: A three-year follow-up study,Dalakas M.C.,143022,European Neurology,25,5,14,1,0,1,0,15
1986,Post-poliomyelitis neuromuscular symptoms,"Moskowitz E., McIntyre Jr. H.D., Dalakas M.C.",284793,New England Journal of Medicine,315,14,0,0,0,0,0,0
1986,Polymyositis in an immunodeficiency disease in monkeys induced by a type D retrovirus,"Dalakas M.C., London W.T., Gravell M., Sever J.L.",283878,Neurology,36,4,10,1,0,1,0,11
1986,Administration of recombinant human leukocyte ?2-interferon in patients with amyotrophic lateral sclerosis,"Dalakas M.C., Aksamit A.J., Madden D.L., Sever J.L.",39942,Archives of Neurology,43,9,3,1,0,1,0,4
1986,Chronic idiopathic ataxic neuropathy,Dalakas M.C.,3645134,Annals of Neurology,19,6,41,3,3,6,1,48
1986,Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: Species distribution and partial characterization of epitopes,"Ilyas A.A., Dalakas M.C., Brady R.O., Quarles R.H.",68993,Brain Research,385,1,14,3,1,4,0,18
1986,A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms,"Dalakas M.C., Elder G., Halett M.",284793,New England Journal of Medicine,314,15,94,8,3,11,1,106
1986,Characterization of amyloid deposits in biopsies of 15 patients with 'sporadic' (non-familial or plasma cell dyscrasic) amyloid polyneuropathy,"Dalakas M.C., Cunningham G.",16322,Acta Neuropathologica,69, 1-2,3,0,0,0,0,3
1986,Subacute painful myopathy from chronic propoxyphene napsylate abuse,Dalakas M.C.,987484,Journal of the American Medical Association,255,13,0,0,0,0,0,0
1986,Thymosin ?4 is a shared antigen between lymphoid cells and oligodendrocytes of normal human brain,"Dalakas M.C., Trapp B.D.",3645134,Annals of Neurology,19,4,7,0,0,0,1,8
1986,Specificity of human IgM monoclonal antibodies from patients with peripheral neuropathy,"O'Shannessy D.J., Ilyas A.A., Dalakas M.C.",1655728,Journal of Neuroimmunology,11,2,8,0,0,0,0,8
1985,Polyneuropathy with monoclonal gammopathy: Glycolipids are frequently antigens for IgM paraproteins,"Ilyas A.A., Quarles R.H., Dalakas M.C., Brady R.O.",278424,Proceedings of the National Academy of Sciences of the United States of America,82,19,20,1,1,2,1,23
1985,Motor control in humans with large-fiber sensory neuropathy,"Sanes J.N., Mauritz K.-H., Dalakas M.C., Evarts E.V.",7219075,Human Neurobiology,4,2,60,5,5,10,2,72
1985,Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups,"Ilyas A.A., Quarles R.H., Dalakas M.C.",3645134,Annals of Neurology,18,6,55,1,3,4,1,60
1985,Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome,"Bernardini I., Rizzo W.B., Dalakas M.",219738,Journal of Clinical Investigation,75,4,26,0,3,3,1,30
1984,"Late postpoliomyelitis muscular atrophy: clinical, virologic, and immunologic studies.","Dalakas M.C., Sever J.L., Madden D.L., Papadopoulos N.M., Shekarchi I.C., Albrecht P., Krezlewicz A.",1620886,Reviews of Infectious Diseases,6, ,15,1,0,1,1,17
1984,Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies,"Dalakas M.C., Papadopoulos N.M.",3645134,Annals of Neurology,15,6,3,0,0,0,0,3
1984,Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management,"Dalakas M.C., Teravainen H., Engel W.K.",39942,Archives of Neurology,41,7,22,0,2,2,1,25
1984,Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy,"Dalakas M.C., Fujihara S., Askanas V.",29440,American Journal of Pathology,116,3,7,1,0,1,1,9
1983,Treatment of polyneuropathy in Waldenstrom's macroglobulinemia: Role of paraproteinemia and immunologic studies,"Dalakas M.C., Flaum M.A., Rick M.",283878,Neurology,33,11,13,1,0,1,0,14
1983,Increased circulation of T lymphocytes bearing surface thymosin ?1 in patients with myasthenia gravis: Effect of thymectomy,"Dalakas M.C., Rose J.W., Paul J.",283878,Neurology,33,2,0,0,0,0,0,0
1983,Treatment of 'permanent' muscle weakness in familial hypokalemic periodic paralysis,"Dalakas M.C., Engel W.K.",0148639X,Muscle and Nerve,6,3,9,3,1,4,0,13
1983,Phosphoglycerate kinase deficiency: Another cause of recurrent myoglobinuria,"DiMauro S., Dalakas M., Miranda A.F.",3645134,Annals of Neurology,13,1,17,4,0,4,1,22
1981,Phosphoglycerate kinase deficiency: a new cause of recurrent myoglobinuria.,"DiMauro S., Dalakas M., Miranda A.F.",659479,Transactions of the American Neurological Association,106, ,3,1,0,1,0,4
1981,Identification of human thymic epithelial cells with antibodies to thymosin alpha 1 in myasthenia gravis.,"Dalakas M.C., Engel W.K., McClure J.E., Goldstein A.L., Askanas V.",778923,Annals of the New York Academy of Sciences,377, ,0,0,0,0,0,0
1981,Splenic and total-body irradiation treatment of myasthenia gravis.,"Engel W.K., Lichter A.S., Dalakas M.C.",778923,Annals of the New York Academy of Sciences,377, ,3,0,1,1,0,4
1981,Immunocytochemical localization of thymosin ?1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures,"Dalakas M.C., Engel W.K., McClure J.E.",0022510X,Journal of the Neurological Sciences,50,2,10,0,0,0,0,10
1981,Chronic relapsing (dysimmune) polyneuropathy: Pathogenesis and treatment,"Dalakas M.C., Engel W.K.",3645134,Annals of Neurology,9, ,51,3,6,9,5,65
1981,Polyneuropathy with monoclonal gammopathy: Studies of 11 patients,"Dalakas M.C., Engel W.K.",3645134,Annals of Neurology,10,1,26,0,0,0,0,26
1981,Amyloid in hereditary amyloid polyneuropathy is related to prealbumin,"Dalakas M.C., Engel W.K.",39942,Archives of Neurology,38,7,2,0,1,1,0,3
1980,Thymosin alpha 1 in myasthenia gravis.,"Dalakas M.C., Engel W.K., McClure J.E., Goldstein A.L.",284793,New England Journal of Medicine,302,19,1,0,0,0,0,1
1980,Human Schwann cells in tissue culture. Histochemical and ultrastructural studies,"Askanas V., Engel W.K., Dalakas M.C.",39942,Archives of Neurology,37,6,7,0,1,1,0,8
1980,Successful treatment of polyneuropathy in waldenstrom macroglobulinemia (WM): Role of dysproteinemia in pathogenesis of the neuropathy,"Dalakas M.C., Flaum M., Engel W.K.",283878,Neurology,30,4,0,0,0,0,0,0
1980,Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy,"Dalakas M.C., Engel W.K.",39942,Archives of Neurology,37,10,20,1,2,3,0,23
1980,Nature of the reversible white matter lesion in multiple sclerosis. Effects of acute inflammation on myelinated tissue studied in the rabbit eye,"Dalakas M., Wright R.G., Prineas J.W.",68950,Brain,103,3,2,0,0,0,0,2
1980,CSF 'monoclonal' bands in chronic relapsing polyneuropathy,"Dalakas M.C., Houff S.A., Engel W.K.",283878,Neurology,30,8,6,0,0,0,0,6
1979,Role of immunoglobulin light chains in the pathogenesis of amyloid polyneuropathy associated with occult plasma-cell dyscrasia.,"Dalakas M.C., Engel W.K.",659479,Transactions of the American Neurological Association,104, ,1,0,0,0,0,1
1978,Leukoencephalopathy in oculocraniosomatic neuromuscular disease with ragged-red fibers. Mitochondrial abnormalities demonstrated by computerized tomography,"Bertorini T., Engel W.K., Di Chiro G., Dalakas M.",39942,Archives of Neurology,35,10,2,0,0,0,0,2
